Beam Therapeutics
-$5.28 (-8.13%) Today
+$1.31 (+2.19%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BEAM and other ETFs, options, and stocks.
About BEAM
Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing.
CEO
John Evans
Employees
181
Headquarters
Cambridge, Massachusetts
Founded
2017
BEAM Key Statistics
Market cap
4.07B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.36M
High today
$67.63
Low today
$59.27
Open price
$67.05
Volume
1.38M
52 Week high
$138.52
52 Week low
$56.34
Analyst ratings
70%
of 10 ratings
Buy
70%
Hold
30%
Sell
0%
BEAM Earnings
-$3.35
-$2.23
-$1.12
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 14, Pre-Market